| ²é¿´: 579 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
hljmmjÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
°ïæ·ÒëÕªÒª7ÐÐ,Íò·Ö¸Ðл
|
|
|
Key results: Pre-incubation of neutrophils with montelukast resulted in dose-related inhibition of the generation of reactive oxygen species and leukotriene B4 by chemoattractant-activated neutrophils, as well as release of elastase, all of which were maximal at 2 mmol¡¤L-1 (mean percentages of the control values of 30 1, 12 3 and 21 3 respectively; P < 0.05). From a mechanistic perspective, treatment of chemoattractant-activated neutrophils with montelukast resulted in significant reduc- tions in both post-peak cytosolic Ca2+ concentrations and store-operated Ca2+ influx. These montelukast-mediated alterations in Ca2+ handling by the cells were associated with a significant elevation in basal cAMP levels, which resulted from inhibition of cyclic nucleotide phosphodiesterases. Conclusions and implications: Montelukast, primarily a cysteinyl leukotriene (CysLT1) receptor antagonist, exhibited previously undocumented, secondary, neutrophil-directed anti-inflammatory properties, which appeared to be cAMP-dependent. |
» ²ÂÄãϲ»¶
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ10È˻ظ´
µ÷¼Á0855-288
ÒѾÓÐ5È˻ظ´
µç×ÓÐÅÏ¢µ÷¼Á½»²æÑ§¿ÆÓÐÍÆ¼öÂð
ÒѾÓÐ6È˻ظ´
266Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏ¿ÆÑ§Ó빤³Ì¿¼ÑÐ
ÒѾÓÐ10È˻ظ´
283·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ29È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
085600²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ23È˻ظ´
baoshanqiu
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 204
- Ó¦Öú: 103 (¸ßÖÐÉú)
- ½ð±Ò: 15293.5
- ºì»¨: 41
- Ìû×Ó: 1611
- ÔÚÏß: 431.6Сʱ
- ³æºÅ: 3856202
- ×¢²á: 2015-05-08
- ÐÔ±ð: GG
- רҵ: 賦µÀÃâÒßÏà¹Ø¼²²¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
hljmmj: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2016-01-04 09:01:20
hljmmj: ½ð±Ò+10, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2016-01-04 09:01:20
|
Ö÷Òª½á¹û£º½«ÖÐÐÔÁ£Ï¸°ûÓëÃÏÂ³Ë¾ÌØÔ¤ÅàÑøµ¼Ö¼ÁÁ¿Ïà¹ØµØÒÖÖÆ»¯Ñ§Ç÷»¯¼Á¼¤»îÖÐÐÔÁ£Ï¸°û»îÐÔÑõ´ØºÍ°×ÈýÏ©B4µÄ²úÉú¼°µ¯ÐÔµ°°×øµÄÊÍ·Å£¬ËùÓÐÖµ¾ùÔÚ2 mmol¡¤L-1´ï¸ß·å£¨¶ÔÕÕÖµµÄƽ¾ù°Ù·ÖÂÊ·Ö±ðΪ 30.1, 12.3 ºÍ 21.3; P < 0.05)¡£´Ó»úÀíÉÏ¿´£¬»¯Ñ§Ç÷»¯¼Á¼¤»îµÄÖÐÐÔÁ£Ï¸°û¾ÃÏÂ³Ë¹ÌØ´¦Àíµ¼Ö·åºóϸ°ûÖʸÆÀë×ÓŨ¶ÈºÍ¸Æ³Øµ÷¿Ø¸ÆÀë×ÓÄÚÁ÷¾ùÏÔÖø¼õÉÙ¡£ÕâЩÓÉÃÏÂ³Ë¾ÌØ½éµ¼µÄϸ°û¶Ô¸ÆÀë×Ó´¦ÀíÄÜÁ¦µÄ¸Ä±äÓë»·ºËÜÕËáÁ×Ëá¶þõ¥Ã¸ÒÖÖÆÒýÆðcAMP»ù´¡Ë®Æ½ÏÔÖøÉý¸ßÓйء£ ½áÂÛ¼°º¬Ò⣺Ê×ÏÈ£¬ÃÏÂ³Ë¾ÌØ×÷Ϊ°ëë×°±õ£°×ÈýÏ© (CysLT1)ÊÜÌåÞ׿¹¼ÁÏÈǰδÓб¨µÀ£¬Æä´Î£¬¶ÔÖÐÐÔÁ£Ï¸°ûµÄ¿¹Ñ×Ö¢ÌØÐÔ±íÏÖΪ cAMPÒÀÀµÐÔ¡£ |
2Â¥2015-12-31 01:40:44














»Ø¸´´ËÂ¥
10